New Vernon Capital Holdings Ii LLC Ironwood Pharmaceuticals Inc Transaction History
New Vernon Capital Holdings Ii LLC
- $185 Million
- Q2 2024
A detailed history of New Vernon Capital Holdings Ii LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, New Vernon Capital Holdings Ii LLC holds 21,572 shares of IRWD stock, worth $91,249. This represents 0.08% of its overall portfolio holdings.
Number of Shares
21,572
Previous 52,443
58.87%
Holding current value
$91,249
Previous $456,000
69.3%
% of portfolio
0.08%
Previous 0.24%
Shares
8 transactions
Others Institutions Holding IRWD
# of Institutions
246Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$96.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$91.2 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$69.3 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$39.1 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$37.7 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $648M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...